We report a novel RHCE*02 allele in a Swedish blood donor that is characterized by the change; c.460A>G (Arg154Gly). The blood donor's RBCs showed variable reactivity with different monoclonal anti-C and anti-e and antigen strength was markedly weakened. We believe these changes represent both a quantitative and qualitative alteration of the antigens encoded by this allele.
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Background: Rh blood group antigens are carried on two similar multipass membrane proteins encoded by RHD and RHCE. RHD encodes D and several partial D-associated low prevalence antigens whereas RHCE encodes C, E, c, e as well as many other antigens of high or low prevalence. In addition, mutations/polymorphisms in the genes may affect the level of protein expression. Results: Tests with anti-C revealed weak reactivity only with one reagent, which contained the MS273 clone; while tests with anti-e revealed weak reactivity with one of two anti-e reagents that contained a blend of MS16/MS21/MS63 clones and a 4+ reaction with anti-e containing clone BS260. The other reagents were nonreactive ( 
Discussion and Conclusions:
We describe a novel RHCE*02 allele that gives rise to an altered expression of both the C and e antigens. Residue 154 is associated with the start of the 5 th transmembrane helix and it is likely that a change from arginine to glycine could affect how the protein is inserted into the RBC membrane, however this remains unproven in the absence of expression studies The amino acid polymorphisms responsible for C and e antigens are encoded by exon 2 and exon 5, respectively and are thus not directly affected but transmembrane alterations in the similar RhD protein have been shown to cause both quantitative and qualitative changes to RhD. 2 The failure of the RBCs to react with 4 of 6 monoclonal anti-e, together with the strong positivity with anti-e clone BS260 and weaker reactivity with one of the two monoclonal reagent blends, suggests that the e antigen expressed by this allele is a partial antigen. This raises the question of whether this donor is at risk of producing anti-e if challenged. This question was answered in part by analysis of samples from a patient, also of Swedish descent, whose RBCs originally typed C−c+E+e+ w and whose plasma contained an alloanti-e. DNA analysis of RHCE revealed heterozygosity for RHCE*C/c and RHCE*E/e as well as c.460A/G. While further samples could not be obtained for additional serological testing, RHCE*C-specific sequence analysis confirmed that c.460G was carried on this allele. We conclude that an RHCE*02 allele containing the change c.460A>G gives rise to C and e antigens that are both qualitatively and quantitatively altered, and that individuals with this allele risk being not only mistyped for these antigens but at risk of producing alloanti-e.
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